Genetics of phenylketonuria: then and now

N Blau - Human mutation, 2016 - Wiley Online Library
More than 950 phenylalanine hydroxylase (PAH) gene variants have been identified in
people with phenylketonuria (PKU). These vary in their consequences for the residual level …

Molecular genetics and diagnosis of phenylketonuria: state of the art

N Blau, N Shen, C Carducci - Expert review of molecular …, 2014 - Taylor & Francis
Detection of individuals with phenylketonuria (PKU), an autosomal recessively inherited
disorder in phenylalanine degradation, is straightforward and efficient due to newborn …

Structural mechanism for tyrosine hydroxylase inhibition by dopamine and reactivation by Ser40 phosphorylation

MT Bueno-Carrasco, J Cuéllar, MI Flydal… - Nature …, 2022 - nature.com
Tyrosine hydroxylase (TH) catalyzes the rate-limiting step in the biosynthesis of dopamine
(DA) and other catecholamines, and its dysfunction leads to DA deficiency and …

Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators

AC Muntau, J Leandro, M Staudigl, F Mayer… - Journal of inherited …, 2014 - Springer
To attain functionality, proteins must fold into their three-dimensional native state. The
intracellular balance between protein synthesis, folding, and degradation is constantly …

Acute intermittent porphyria: an overview of therapy developments and future perspectives focusing on stabilisation of HMBS and proteostasis regulators

HJ Bustad, JP Kallio, M Vorland, V Fiorentino… - International Journal of …, 2021 - mdpi.com
Acute intermittent porphyria (AIP) is an autosomal dominant inherited disease with low
clinical penetrance, caused by mutations in the hydroxymethylbilane synthase (HMBS) …

The molecular basis of galactosemia—Past, present and future

DJ Timson - Gene, 2016 - Elsevier
Galactosemia, an inborn error of galactose metabolism, was first described in the 1900s by
von Ruess. The subsequent 100 years has seen considerable progress in understanding …

Second-generation pharmacological chaperones: beyond inhibitors

ML Tran, Y Génisson, S Ballereau, C Dehoux - Molecules, 2020 - mdpi.com
Protein misfolding induced by missense mutations is the source of hundreds of
conformational diseases. The cell quality control may eliminate nascent misfolded proteins …

Inborn errors of metabolism

F Ezgu - Advances in clinical chemistry, 2016 - Elsevier
Inborn errors of metabolism are single gene disorders resulting from the defects in the
biochemical pathways of the body. Although these disorders are individually rare …

Pharmacological chaperoning: a primer on mechanism and pharmacology

NJ Leidenheimer, KG Ryder - Pharmacological research, 2014 - Elsevier
Approximately forty percent of diseases are attributable to protein misfolding, including those
for which genetic mutation produces misfolding mutants. Intriguingly, many of these mutants …

Tetrahydrobiopterin (BH4) treatment stabilizes tyrosine hydroxylase: Rescue of tyrosine hydroxylase deficiency phenotypes in human neurons and in a knock‐in …

K Jung‐kc, A Tristán‐Noguero… - Journal of Inherited …, 2024 - Wiley Online Library
Proteostatic regulation of tyrosine hydroxylase (TH), the rate‐limiting enzyme in dopamine
biosynthesis, is crucial for maintaining proper brain neurotransmitter homeostasis. Variants …